RETRACTED: COL10A1-DDR2 axis promotes the progression of pancreatic cancer by regulating MEK/ERK signal transduction

Zhihui Wen, Jingbo Sun, Junjie Luo, Yun Fu, Yue Qiu, Yanyan Li, Yangwei Xu, Hongmei Wu, Qingling ZhangFrontiers in Oncology 2022 · DOI · OpenAlex

Notice: This article has been officially retracted by the journal Frontiers in Oncology. The following summary represents the claims made by the authors at the time of publication, which should not be considered established scientific fact.

Original article header showing the retraction watermark.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignant tumors with a poor prognosis. Type X collagen α 1 chain (COL10A1), a member of the collagen family, is a gene associated with the progression of a variety of human tumors, but the specific function and molecular mechanism of COL10A1 in pancreatic cancer remain unclear. Our study found that COL10A1 is highly expressed in pancreatic cancer cells and tissues, and its high expression is related to poor prognosis and some clinicopathological features, such as tumor size and differentiation. Biological functional experiments showed that overexpression of COL10A1 enhanced the proliferation and migration of PDAC cells. Interestingly, discoid protein domain receptor 2 (DDR2), the receptor of COL10A1, is regulated by COL10A1. We found that the COL10A1-DDR2 axis activates the mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway, which leads to epithelial-mesenchymal transformation (EMT) and accelerates the progression of pancreatic cancer. In summary, COL10A1 regulates PDAC cell proliferation and MEK/ERK signaling pathways by binding to DDR2 to promote migration, invasion and EMT. Our study suggested that COL10A1 might be a critical factor in promoting PDAC progression. More research is needed to confirm COL10A1 as a potential biomarker and therapeutic target for PDAC.

Introduction

Pancreatic ductal adenocarcinoma (PDAC) remains a significant challenge in oncology due to its aggressive nature and typically late-stage diagnosis. Identifying reliable biomarkers is crucial for improving prognosis and developing targeted therapies. While Type X collagen (COL10A1) was previously noted to be elevated in several tumor types, its functional role in the progression of pancreatic cancer was not well-defined. This study aimed to investigate whether COL10A1 serves as a functional driver of PDAC growth and metastasis rather than being a mere byproduct of the tumor microenvironment.

Methodology

The researchers utilized a multi-faceted approach to explore the role of COL10A1:

  • Bioinformatics Analysis: Initial screening of differentially expressed genes was conducted using the GSE15471 dataset from the Gene Expression Omnibus (GEO) and the GEPIA web tool, which integrates TCGA and GTEx data.
  • Clinical Validation: Immunohistochemistry (IHC) was performed on 64 paraffin-embedded patient specimens from Nanfang Hospital (2016–2018) to correlate COL10A1 expression with clinical outcomes.
  • In Vitro and In Vivo Models: PDAC cell lines were modified using lentiviral vectors for knockdown or overexpression of COL10A1 and DDR2. These cells were then used in functional assays and mouse models (subcutaneous and orthotopic) to observe tumor growth and liver metastasis.
  • Molecular Signaling: Physical interactions and pathway activation were mapped using Western blotting, Co-Immunoprecipitation (Co-IP), and Immunofluorescence (IF).

Results

The study reported several key findings regarding the COL10A1-DDR2 axis:

  • Expression and Prognosis: COL10A1 expression was significantly higher in PDAC tissues (81.3%) compared to normal tissues (14.1%). High expression levels were statistically associated with shorter overall survival and advanced tumor stages.
  • Functional Impact: Overexpression of COL10A1 promoted cell proliferation and migration, while its knockdown significantly inhibited tumor growth and reduced liver metastasis in vivo.
  • Mechanism of Action: The authors identified DDR2 as the specific receptor for COL10A1. They proposed that the COL10A1-DDR2 interaction activates the MEK/ERK signaling pathway, which in turn drives the Epithelial-Mesenchymal Transition (EMT), a critical step for cancer cell invasion and metastasis.

Discussion and Retraction Notice

While the authors concluded that COL10A1 is a critical factor in PDAC progression and a potential therapeutic target, these findings must be viewed with extreme caution. The study was limited by a relatively small clinical cohort and an incomplete explanation of the structural nature of the COL10A1-DDR2 binding.

Most importantly, this article has been RETRACTED. The retraction implies that the scientific community or the journal editors identified significant issues with the data or conclusions post-publication. Consequently, the proposed COL10A1-DDR2-MEK/ERK axis cannot be considered a verified mechanism in pancreatic cancer without independent replication and validation.

Summary updated

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignant tumors with a poor prognosis. Type X collagen α 1 chain (COL10A1), a member of the collagen family, is a gene associated with the progression of a variety of human tumors, but the specific function and molecular mechanism of COL10A1 in pancreatic cancer remain unclear. Our study found that COL10A1 is highly expressed in pancreatic cancer cells and tissues, and its high expression is related to poor prognosis and some clinicopathological features, such as tumor size and differentiation. Biological functional experiments showed that overexpression of COL10A1 enhanced the proliferation and migration of PDAC cells. Interestingly, discoid protein domain receptor 2 (DDR2), the receptor of COL10A1, is regulated by COL10A1. We found that the COL10A1-DDR2 axis activates the mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway, which leads to epithelial-mesenchymal transformation (EMT) and accelerates the progression of pancreatic cancer. In summary, COL10A1 regulates PDAC cell proliferation and MEK/ERK signaling pathways by binding to DDR2 to promote migration, invasion and EMT. Our study suggested that COL10A1 might be a critical factor in promoting PDAC progression. More research is needed to confirm COL10A1 as a potential biomarker and therapeutic target for PDAC.
BibTeX
@inproceedings{wen2022retracted,
  author = {Zhihui Wen and Jingbo Sun and Junjie Luo and Yun Fu and Yue Qiu and Yanyan Li and Yangwei Xu and Hongmei Wu and Qingling Zhang},
  title = {{RETRACTED: COL10A1-DDR2 axis promotes the progression of pancreatic cancer by regulating MEK/ERK signal transduction}},
  booktitle = {Frontiers in Oncology},
  year = {2022},
  doi = {10.3389/fonc.2022.1049345},
}
Figure